Beneficios clínicos de la resincronización cardiaca / Clinical benefit in cardiac resynchronization
Arch. cardiol. Méx
;
79(supl.2): 71-74, dic. 2009.
Article
in Spanish
| LILACS
| ID: lil-565561
ABSTRACT
Despite the improvement in pharmacologic treatment of heart failure, many patients continue to have severe persistent symptoms, and their prognosis remains poor. One of the most recent advances in heart failure management is the concept of cardiac resynchronization therapy (CRT). Large clinical trials have demonstrated morbidity and mortality benefits of CRT in patients with moderate to severe drug refractory heart failure (New York Heart Association [NYHA] functional class III or IV), and ejection fraction < or = 35% with QRS duration > or = 120 ms.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Cardiac Pacing, Artificial
/
Heart Failure
Limits:
Humans
Language:
Spanish
Journal:
Arch. cardiol. Méx
Journal subject:
Cardiology
Year:
2009
Type:
Article
Affiliation country:
Mexico
Institution/Affiliation country:
Hospital de Especialidades Dr Antonio Fraga Mouret/MX
Similar
MEDLINE
...
LILACS
LIS